![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
The daily Top 10 COVID papers |
Ovarian Neoplasms |
Free Subscription
2 Am J Obstet Gynecol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Ovarian Neoplasms is free of charge.
Validation of an enhanced recovery after surgery protocol in gynecological
surgery: an Italian randomized study.
Am J Obstet Gynecol. 2020 Jul 8. pii: S0002-9378(20)30720.
PubMed
Abstract available
A cesarean delivery sequela: Scar rupture and tumor spill during laparoscopic
hysterectomy for endometrial cancer.
Am J Obstet Gynecol. 2020 Mar 18. pii: S0002-9378(20)30337.
PubMed
DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and
metabolic reprogramming in high grade serous ovarian cancer.
Cancer Lett. 2020 Nov 19. pii: S0304-3835(20)30603.
PubMed
Abstract available
Incidence and risk factors for postoperative venous thromboembolism in patients
with ovarian cancer: Systematic review and meta-analysis.
Gynecol Oncol. 2020 Nov 18. pii: S0090-8258(20)34121.
PubMed
Abstract available
Modified fragility index and surgical complexity score are able to predict
postoperative morbidity and mortality after cytoreductive surgery for advanced
ovarian cancer.
Gynecol Oncol. 2020 Sep 4. pii: S0090-8258(20)33823.
PubMed
Abstract available
Embedding a genetic counselor into oncology clinics improves testing rates and
timeliness for women with ovarian cancer.
Gynecol Oncol. 2020 Nov 20. pii: S0090-8258(20)34111.
PubMed
Abstract available
Development of a clinically relevant ovarian cancer model incorporating surgical
cytoreduction to evaluate treatment of micro-metastatic disease.
Gynecol Oncol. 2020 Nov 20. pii: S0090-8258(20)34117.
PubMed
Abstract available
Analysis in epithelial ovarian cancer identifies KANSL1 as a biomarker and target
gene for immune response and HDAC inhibition.
Gynecol Oncol. 2020 Nov 20. pii: S0090-8258(20)34116.
PubMed
Abstract available
Feasibility and rationale of a novel approach in advanced ovarian cancer surgery:
Bat- shaped en-bloc total peritonectomy and total hysterectomy
salpingo-oophorectomy with or without rectosigmoid resection (Sarta-Bat
approach).
Gynecol Oncol. 2020 Nov 21. pii: S0090-8258(20)34122.
PubMed
Abstract available
A multicenter open-label randomized phase II trial of paclitaxel plus EP-100, a
novel LHRH receptor-targeted, membrane-disrupting peptide, versus paclitaxel
alone for refractory or recurrent ovarian cancer.
Gynecol Oncol. 2020 Nov 23. pii: S0090-8258(20)34124.
PubMed
Abstract available
Genetically predicted circulating protein biomarkers and ovarian cancer risk.
Gynecol Oncol. 2020 Nov 24. pii: S0090-8258(20)34127.
PubMed
Abstract available
Tumor-associated macrophage targeted therapeutics in ovarian cancer.
Int J Cancer. 2020 Nov 24. doi: 10.1002/ijc.33408.
PubMed
Abstract available
Evaluation of preoperative prediction of intestinal invasion in patients with
ovarian cancer.
Int J Gynaecol Obstet. 2020 Nov 22. doi: 10.1002/ijgo.13492.
PubMed
Abstract available
CBX7 binds the E-box to inhibit TWIST-1 function and inhibit tumorigenicity and
metastatic potential.
Oncogene. 2020;39:3965-3979.
PubMed
Abstract available
XCL1 expression correlates with CD8-positive T cells infiltration and PD-L1
expression in squamous cell carcinoma arising from mature cystic teratoma of the
ovary.
Oncogene. 2020 Mar 2. pii: 10.1038/s41388-020-1237.
PubMed
Abstract available
Initialization of epithelial cells by tumor cells in a metastatic
microenvironment.
Oncogene. 2020;39:2638-2640.
PubMed
Aberrant granulosa cell-fate related to inactivated p53/Rb signaling contributes
to granulosa cell tumors and to FOXL2 downregulation in the mouse ovary.
Oncogene. 2019 Nov 19. pii: 10.1038/s41388-019-1109.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by